Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
This ribonuclease gene is a novel member of the Rh/T2/S-glycoprotein class of extracellular ribonucleases. De plus, nous expédions Ribonuclease T2 Kits (59) et Ribonuclease T2 Protéines (12) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 64 products:
Dog (Canine) Polyclonal RNASET2 Primary Antibody pour IHC, WB - ABIN2777766
Campomenosi, Salis, Lindqvist, Mariani, Nordström, Acquati, Taramelli: Characterization of RNASET2, the first human member of the Rh/T2/S family of glycoproteins. dans Archives of biochemistry and biophysics 2006
Show all 2 Pubmed References
RNASET2 is the enzyme that degrades the RNAs
RNASET2, an IBD susceptibility gene, is a component of TL1A (Montrer TNFSF15 Anticorps)-mediated pathways regulating cytokine production.
inhibits melanocyte outgrowth through interacting with shootin1 (Montrer KIAA1598 Anticorps); this effect may be associated with vitiligo (Montrer MITF Anticorps) pathogenesis
Biological features allow to put forward the hypothesis that the RNASET2 protein can act as a molecular barrier for limiting the damages and tissue remodeling events occurring during the earlier step of cell transformation.
RNASET2 may contribute to the development of vitiligo (Montrer MITF Anticorps) by inhibiting TNF Receptor-Associated Factor 2 (Montrer TRAF2 Anticorps) expression and lead directly to apoptosis of melanocytes
describe a multi-step strategy that allows production of highly pure, catalytically competent recombinant RNASET2 in both wild-type and mutant forms
RNASET2 has antitumorigenic and antiangiogenic activities; a truncated version of human RNASET2, starting at E50 (trT2-50) and devoid of ribonuclease activity, has actin binding and anticancer-related biological activities
RNASET2 tag SNP but not CCR6 polymorphisms is associated with autoimmune thyroid diseases in the Chinese Han population
Results show that downregulation of RNASET2 and GGNBP2 (Montrer GGNBP2 Anticorps) in drug-resistant ovarian cancer tissues/cells contributes to the regulation of drug resistance in ovarian cancer.
RNASET2 contributes to vitiligo (Montrer MITF Anticorps) pathogenesis by inhibiting TRAF2 (Montrer TRAF2 Anticorps) expression.
This ribonuclease gene is a novel member of the Rh/T2/S-glycoprotein class of extracellular ribonucleases. It is a single copy gene that maps to 6q27, a region associated with human malignancies and chromosomal rearrangement.
, polyU-preferential ribonuclease
, ribonuclease T2
, RNase Dre2
, ribonuclease t2